Exact Mass: 244.1412

Geranylbenzoquinone

2-(3,7-dimethylocta-2,6-dienyl)cyclohexa-2,5-diene-1,4-dione

Hydroxyprolyl-Leucine

2-{[hydroxy(4-hydroxypyrrolidin-2-yl)methylidene]amino}-4-methylpentanoate

Hydroxyprolyl-Leucine is a dipeptide composed of hydroxyproline and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Hydroxyprolyl-Isoleucine

2-{[hydroxy(4-hydroxypyrrolidin-2-yl)methylidene]amino}-3-methylpentanoate

Hydroxyprolyl-Isoleucine is a dipeptide composed of hydroxyproline and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Isoleucylhydroxyproline

(2S,4R)-1-[(2S,3S)-2-amino-3-methylpentanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

Isoleucylhydroxyproline is a dipeptide composed of isoleucine and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Leucylhydroxyproline

(2S,4R)-1-[(2S)-2-amino-4-methylpentanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

Leucylhydroxyproline is a dipeptide composed of leucine and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Hexanoylglutamine

(2S)-4-(C-hydroxycarbonimidoyl)-2-[(1-hydroxyhexylidene)amino]butanoic acid

(2R,4S)-1-Tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate

(2R,4S)-1-Tert-butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylic acid

Veliparib

2-(2-Methylpyrrolidin-2-yl)-1H-1,3-benzodiazole-7-carboximidate

C13H16N4O (244.1324)

Cordiaquinol C

Conicol

Linderoxide

(4aS,5aS,6aR,6bS)-4,4a,5,5a,6,6a,6b,7-Octahydro-3-(methoxymethyl)-6b-methyl-5-methylenecycloprop[2,3]indeno[5,6-b]furan

2-Hydroxy-7-methoxycadalene

Methyl 3,4-dihydro-5-methyl-8-isopropyl-2-naphthalenecarboxylate

Isolinderoxide

(5aR,6aS,6bR)-rel-4,5a,6,6a,6b,7-hexahydro-3-(methoxymethyl)-5,6b-dimethylcycloprop[2,3]indeno[5,6-b]furan

14-acetoxy-tetradeca-2t,4t,8t,10t-tetraen-6-yne|Ac-4,6,10,12-Tetradecatetraen-8-yn-2-ol,|Tetradecatetra-4,6,10,12-en-8-in-1-ol-acetat

DTXSID70772909

Terramide B

C16H20O2

Me ether-(2R,5S,1E,3E)-form-Tetrahydro-5-(1,3-undecadiene-5,7-diynyl)-2-furanol,

Me ether-(2R*,5S*,1E,3E)-form-Tetrahydro-5-(1,3-undecadiene-5,7-diynyl)-2-furanol,

6alpha-Furanoeremophilan-15, 6-olide|Furanoermophilan-14, 6-olide

NSC317294

Cordiachromen A

podoandin

CHEBI:67919

Aspergilliamide B

ZINC68562275

C13H24O2S (244.1497)

chlomultin D

L-gamma-Glutamyl-2-aminohexan-3-on

6E,8E,12E,14E-Hexadecatetraen-10-ynoic acid

(6E,8E,12E,14E)-hexadeca-6,8,12,14-tetraen-10-ynoic acid

6E,8E,12E-Hexadecatrien-10-ynoic acid

(6E,8E,12E,14Z)-hexadeca-6,8,12,14-tetraen-10-ynoic acid

6-Methoxy-4a-methyl-3,4,4a,9,10,10a-hexahydro-2(1H)-phenanthrenone

14-METHOXY-4,4-BISNOR-8,11,13-PODOCARPATRIEN-3-ONE

Hpro-ile

1-(2-amino-3-methylpentanoyl)-4-hydroxypyrrolidine-2-carboxylic acid

Hpro-leu

1-(2-amino-4-methylpentanoyl)-4-hydroxypyrrolidine-2-carboxylic acid

Ile-hpro

2-[(4-hydroxypyrrolidin-2-yl)formamido]-3-methylpentanoic acid

Leu-hpro

2-[(4-hydroxypyrrolidin-2-yl)formamido]-4-methylpentanoic acid

FA 16:6

6E,8E,12E,14E-Hexadecatetraen-10-ynoic acid

1,1-BIS(TRIMETHYLSILYLOXY)-3-METHYL-1,3-BUTADIENE

C11H24O2Si2 (244.1315)

(S)-1-N-Boc-piperazine-3-carboxylicacid methylester

(2E,4E)-5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpenta-2,4-dienal

Indazole-6-boronic acid pinacol ester

(R)-3,3-DIMETHYL-1,1-BINAPHTHALENE-2,2-DIOL

(S)-3,4-DIMETHOXYPHENYLALANINEMETHYLESTER

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid

METHYL (2R,4R)-4-AMINOPYRROLIDINE-2-CARBOXYLATE, N1-BOC PROTECTED

1-(4-Aminophenyl)-3-(1-pyrrolidino)-5-pyrazolone

C13H16N4O (244.1324)

Fenestrel

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen

trans-6-Chloro-1-hexen-1-ylboronic acid pinacol ester

C12H22BClO2 (244.1401)

2-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-2-YL)ACETIC ACID

Tetramethylammonium Sulfate

C8H24N2O4S (244.1457)

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine

6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

buta-1,3-diene,2-methylprop-2-enoic acid,styrene

(4R,5R)-4,5-Di(dimethylaminocarbonyl)-2,2-dimethyldioxolane, 99+\\%

7-amino-1H-Indole-2-carboxylic acid

1-Boc-4-Aminopiperidine-4-carboxylic acid

(E)-1-(1-(FURAN-2-YL)PROP-1-EN-2-YL)CYCLOPROPANAMINE